جست‌وجوی استاد و پژوهشگر

• Exercise Physiology
• Bone Physiology
• Pediatric Exercise Medicine
• +۴ مورد دیگر

Panagiota (Nota) Klentrou is a Distinguished Professor and Dean of the Faculty of Applied Health Sciences at Brock University, specializing in Kinesiology. Her research focuses on exercise physiology , bone development , and the health implications of sport training in youth , particularly examining cellular mechanisms linking exercise, diet, and lifelong bone health. Supported by NSERC, CIHR, Osteoporosis Canada, and the International Gymnastics Federation Education: PhD, FCSEP (Fellow of the Canadian Society of Exercise Physiology) Her work spans bone physiology , inflammatory responses to exercise , and sclerostin-mediated tissue cross-talk , with recent studies exploring the impact of obesogenic diets , acute exercise , and nutritional interventions on skeletal growth and adaptation. Key findings include the role of sprint interval training in modulating adipose tissue Wnt signaling and the effects of dairy consumption on bone turnover markers. Scientific Awards & Distinctions Fellow, Canadian Society for Exercise Physiology (CSEP), 2020 Marilyn Rose Graduate Leadership Award, 2017 TVO's Best Lecturer nominee, 2010 Chancellor’s Chair for Research Excellence, Brock University, 2009 Award for Distinguished Research & Creative Activity, Brock University, 2006 Dr. Klentrou actively supervises graduate and undergraduate students in projects related to bone physiology , inflammation , and exercise adaptation , and collaborates with organizations like Osteoporosis Canada and the International Gymnastics Federation.

Scott Michael Lindhorstمشاهده پروفایل

استادیار

• Neuro-Oncology
• Medical Oncology
• Brain & Spine Tumors
• +۲ مورد دیگر

Scott Michael Lindhorst, MD, is an Assistant Professor in the Department of Neurosurgery at the Medical University of South Carolina (MUSC) College of Medicine. He holds a dual appointment in the Division of Hematology/Medical Oncology within the Department of Medicine. Dr. Lindhorst specializes in neuro-oncology, focusing on central nervous system lymphomas, gliomas, and meningiomas, while also managing brain metastases through clinical trials. Education: BS in Microbiology from University of Florida (2001), MD from University of South Alabama College of Medicine (2005) Training: Residency in Internal Medicine, Fellowship in Hematology/Medical Oncology (University of Alabama at Birmingham), Fellowship in Neuro-Oncology (Duke University Medical Center) His research centers on immuno-oncology , glioblastoma therapy , and epigenetic cancer treatments , with a strong emphasis on clinical trials for novel therapies. Recent publications explore hypermutation in cancer , immune checkpoint inhibition , and programmed necrosis in glioblastoma . Dr. Lindhorst is board-certified in internal medicine, hematology, medical oncology, and neuro-oncology. Clinical practice includes CNS lymphomas , gliomas , meningiomas , and brain metastases , with dedicated clinical trials to advance treatment options.

• Bone Biology
• Skeletal Disorders
• Wnt Signaling Pathways
• +۵ مورد دیگر

Dr. Timur Alexander Yorgan is a prominent researcher at the Department of Osteology and Biomechanics at University Medical Center Hamburg-Eppendorf (UKE). Holding a Dr. rer. nat. degree, he has established himself as a leading figure in bone biology with over 60 publications spanning from 2013 to 2025. His research is deeply integrated with key institutional research areas including the Hamburg Center of Neuroscience and immunology research networks at UKE. Dr. Yorgan's research focuses on skeletal development, bone remodeling, and genetic bone disorders, with particular emphasis on Wnt signaling pathways and their role in bone homeostasis. His work spans multiple approaches from molecular genetics to translational studies, investigating osteoblast and osteocyte biology, genetic mechanisms underlying disorders like osteogenesis imperfecta, and the effects of various mutations on skeletal integrity. Recent research has expanded into the gut-bone axis, mechanobiology of bone cells, and neuro-immune interactions affecting bone metabolism. Analysis of Dr. Yorgan's publication record reveals a consistent trajectory of high-impact research in bone biology. His work increasingly explores interdisciplinary connections between bone metabolism and other physiological systems, with growing emphasis on translational approaches for therapeutic interventions. The research demonstrates sophisticated use of mouse models and molecular techniques to unravel complex bone disorders and identify potential treatment targets. Dr. Yorgan appears to be actively involved in collaborative research across multiple institutions, as evidenced by his extensive publication record with numerous co-authors from various departments and institutions. His work is frequently published in high-impact journals including Journal of Bone and Mineral Research, Nature Communications, and Bone Research. The Department of Osteology and Biomechanics at UKE, where Dr. Yorgan is based, is part of a vibrant research ecosystem that includes the Hamburg Center of Neuroscience and other key research networks focusing on immunology, oncology, and cardiovascular research. This collaborative environment enables interdisciplinary approaches to understanding skeletal disorders and developing novel therapeutic strategies.

Soeren Lienkampمشاهده پروفایل

استادیار

• Molecular Biology
• Genetics
• Developmental Biology
• +۵ مورد دیگر

Prof. Dr. Soeren Lienkamp is an Assistant Professor at the Institute of Anatomy , Faculty of Medicine , University of Zurich . His work bridges digital education and genetic research , focusing on enhancing medical teaching through innovative formats. Research Interests : Genetics, developmental biology, kidney disease modeling, CRISPR applications, digital medical education, and advanced microscopy. Methodologies : Combines Xenopus tropicalis models, deep learning , and bioengineering to study genetic kidney disorders and improve diagnostic tools. Publication Trends : His recent articles highlight predictable genome editing , 3D imaging technologies , and mechanistic insights into kidney and eye development. Earlier works focus on ciliary function , Wnt signaling , and metabolic stress in renal cells.

• Plastic and Reconstructive Surgery
• Hand Surgery
• Genetics of Musculoskeletal Disorders
• +۳ مورد دیگر

Dominic Furniss serves as Professor of Plastic and Reconstructive Surgery at the University of Oxford's Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), concurrently holding an Honorary Consultant Plastic Surgeon position. His clinical expertise centers on hand surgery and supermicrosurgery for lymphoedema treatment. His educational background includes undergraduate medical studies at Trinity College, Cambridge (Junior and Senior Scholar, first-class degree in genetic pathology) followed by clinical training at Oxford University Clinical School. He completed basic surgical training in London before returning to Oxford's Plastic Surgery Department in 2003. Professor Furniss leads pioneering research into genetic and non-genetic causes of hand conditions through multiple initiatives including the Furniss Group, Centre for OA Pathogenesis, and Hand Research Group. His work spans molecular genetics of Dupuytren's disease, carpal tunnel syndrome epidemiology, and kidney stone disease mechanisms. Recent investigations extend to AI applications in health data through the PHAIR study and causal inference methods in genetic epidemiology. Analysis of his 2024-2025 publications reveals a strategic shift toward large-scale epidemiological studies of hand injuries, interdisciplinary genetic research, and AI integration in surgical practice. These works bridge orthopaedics, genetics, and medical informatics with significant real-world clinical implications. His major scientific recognitions include: Pushpa Chopra Award Plenary Prize of the MRS Wellcome Trust Intermediate Fellowship (first awarded to a plastic surgeon) Professor Furniss has secured substantial research funding including the NIHR Clinical Lectureship (2007) and Wellcome Trust Fellowship (2012). He directs multiple research streams: RAMBOH-1 studies, Molecular Genetics of Carpal Tunnel Syndrome project, and HAWAII initiative. His team actively investigates public perceptions of health data sharing for AI through the PHAIR study while advancing supermicrosurgical techniques for lymphoedema. He maintains active leadership in the Athena SWAN gender equality initiative as a Self-assessment team member, demonstrating commitment to inclusive academic culture.

Jason Yiمشاهده پروفایل

استادیار

• Neuroscience
• Molecular Neuroscience
• Developmental Neuroscience
• +۶ مورد دیگر

Dr. Jason Yi is an Assistant Professor of Neuroscience at Washington University School of Medicine (WashU Medicine). His research focuses on understanding the molecular pathways that shape nervous system development and function, with particular emphasis on autism spectrum disorders (ASD). He leads the Yi Lab, which investigates the role of the ubiquitin ligase UBE3A in the brain and its implications for neurodevelopmental disorders. Dr. Yi received his BS in Biochemistry and Molecular Biology from Dickinson College in 2001 and his PhD in Pharmacology from Duke University in 2009. His laboratory is broadly interested in the molecular pathways that shape nervous system development and function, with the ultimate goal of understanding how dysfunction in these pathways contributes to disease. The current focus is on autism spectrum disorders (ASD), using genetic information from human patients to guide in vitro and in vivo experiments employing biochemical, genetic manipulation, cell biological, and microscopy techniques. Dr. Yi's research has significant clinical implications, particularly in understanding how UBE3A dysfunction relates to both Angelman syndrome (caused by lack of UBE3A activity) and autism (caused by excessive UBE3A activity). His lab discovered that a single phosphorylation event in UBE3A turns off its ubiquitin ligase activity, and that mutations in this site are linked to autism. This work bridges disease genetics with a mechanistic understanding of ASD neurobiology and aims to define developmental timepoints for ASD onset. Dr. Yi's research has been recognized with numerous prestigious awards: Ruth K. Broad Biomedical Research Foundation Predoctoral Fellowship (2006) F32 Kirschstein National Research Service Award (2011) Christina Castellana Postdoctoral Fellowship (2011-2014) The University of North Carolina Postdoctoral Award for Research Excellence (2015) Bridge to Independence Award, The Simons Foundation (2017) NARSAD Young Investigator Award, Brain and Behavior Research Foundation (2018) Whitehall Foundation Research Grant (2018) Alfred P. Sloan Foundation Research Fellowship (2019) Dr. Yi's research program is supported by significant grant funding from organizations including The Simons Foundation, Brain and Behavior Research Foundation, and the Whitehall Foundation. His work bridges basic molecular neuroscience with clinical implications for neurodevelopmental disorders, particularly autism spectrum disorders. Through his research, Dr. Yi is contributing to a deeper understanding of the molecular mechanisms underlying ASD, which may ultimately lead to new therapeutic approaches and interventions. The Yi Lab maintains a collaborative research environment focused on cutting-edge neuroscience techniques. The lab combines molecular, cellular, and genetic approaches to study UBE3A function and its role in neurodevelopment. Their work utilizes patient-derived genetic information to guide experimental approaches, ensuring clinical relevance to autism spectrum disorders. Dr. Yi is also actively involved in mentoring graduate students and postdoctoral fellows, contributing to the training of the next generation of neuroscientists.

• Biomechanics/Bioengineering
• Biomedical Sciences
• Muscle Cells
• +۷ مورد دیگر

Woojin Han is an Assistant Professor in the Departments of Orthopedics and Cell, Developmental & Regenerative Biology at the Icahn School of Medicine at Mount Sinai. His research program focuses on the mechanobiology of skeletal muscle stem and progenitor cells, with applications in disease modeling and the development of advanced therapeutics for muscle injuries and degenerative diseases. Dr. Han earned his BS in Biomedical Engineering from the University of Rochester and his MS and PhD in Bioengineering from the University of Pennsylvania. He completed his postdoctoral training at the Georgia Institute of Technology, where he received awards from the American Federation for Aging Research (AFAR) and the NIH. Dr. Han's research integrates biomaterials, bioengineering, and in vivo genetic approaches to investigate cell-matrix interactions and mechanobiological signaling, aiming to uncover the mechanisms driving muscle regeneration and pathology. His work is supported by the National Institutes of Health (NIH) and the Department of Defense (DoD). Analysis of Dr. Han's recent publications reveals a strong focus on muscle regeneration mechanisms, particularly examining the role of extracellular matrix proteins, mechanical confinement, and signaling pathways in muscle stem cell behavior. His research spans from fundamental mechanobiology to translational applications using biomaterials for tissue regeneration. 2025 NEBEC Emerging Investigator Award 2024 Mount Sinai Faculty Council Award for Junior Faculty 2023 Popular Science's The Brilliant 10 2022 Stephen I. Katz Early Stage Investigator Grant Awardee American Federation for Aging Research (AFAR) award NIH award Dr. Han's research is supported by significant funding from the National Institutes of Health (NIH) and the Department of Defense (DoD). His work bridges basic science and clinical applications, with particular emphasis on developing advanced therapeutics for muscle injuries and degenerative diseases. Through his lab, he mentors junior researchers in the fields of biomechanics, bioengineering, and regenerative medicine. Dr. Han leads the Han Lab, which focuses on skeletal muscle regeneration research. The lab employs a multidisciplinary approach combining biomaterials engineering, molecular biology, and advanced imaging techniques to develop novel strategies for enhancing muscle repair and preventing pathological changes following injury.

Yeonhwa Parkمشاهده پروفایل

استاد

• Functional Foods
• Obesity
• Environmental Contaminants
• +۳ مورد دیگر

Yeonhwa Park is a Professor and holder of the Francis Chair in the Department of Food Science at the University of Massachusetts Amherst. Her research focuses on functional foods, bioactive components, and environmental contaminants' effects on obesity and aging. She investigates food bioactives like conjugated linoleic acid (CLA) and environmental pollutants like PFAS to understand their roles in metabolic disorders and aging mechanisms. Her work spans multiple models, including C. elegans, zebrafish, and rodent studies, emphasizing translational applications for human health. Teaching responsibilities include courses such as 'Science of Food' (FS150), 'Biology of Food in Human Health' (FS270), and 'Bioactive Food Components' (FS750). Awards include Clarivate Highly Cited Researcher (2017–2018), Faculty Convocation Award (2015), and the Timothy Mounts Award (2015). Her research has been published in over 150 peer-reviewed articles, with recent emphasis on environmental contaminants' impact on obesity and type 2 diabetes, and the use of C. elegans for screening bioactives. Key findings include CLA's role in fat reduction, PFAS-induced metabolic disruption, and the application of alternative models (e.g., C. elegans) to reduce animal testing. Her lab integrates molecular biology, toxicology, and food science to address global health challenges like the obesity epidemic and environmental toxin exposure.

• Ophthalmology
• Retinal Degeneration
• Nanomedicine
• +۳ مورد دیگر

Dr. Ling Zhu is an Associate Professor and Senior Research Fellow at the Save Sight Institute, University of Sydney. He holds dual affiliations with the Centre for Drug Discovery Innovation and the University of Sydney Nano Institute. His research focuses on retinal diseases, including diabetic retinopathy, age-related macular degeneration, and macular telangiectasia type 2, combining clinical and basic research approaches. Dr. Zhu leads a lab with a postdoc, two research assistants, and one HDR student, emphasizing innovative techniques like human retinal explant culture and nanomedicine. Dr. Zhu obtained his PhD in Biochemistry from Rutgers University (USA) in 2008. His work has attracted over $2 million in research funding in the past five years and includes 93 publications (3590 citations, H-index 34). He is a major author in leading journals like eLife and Ophthalmology . Current research projects include preclinical RNA-LNP therapy for retinal degeneration, targeting retinal metabolism for macular diseases, and developing a 'Macula-on-a-Chip' drug screening platform. His expertise spans biochemistry, molecular biology, and translational nanomedicine. Key achievements include establishing human retinal explant models and advancing lipid nanoparticle-based drug delivery systems. Dr. Zhu collaborates widely, with projects addressing unmet clinical needs in ophthalmology and drug discovery.

Shabaz Mohammedمشاهده پروفایل

دانشیار

• Proteomics
• Mass Spectrometry
• Post-translational Modifications
• +۴ مورد دیگر

Shabaz Mohammed is an Associate Professor of Proteomics at the University of Oxford, holding joint appointments in the Departments of Chemistry and Biochemistry. Since 2020, he has served as Head of the Mechanistic Proteomics research programme at the Rosalind Franklin Institute. His research focuses on advancing proteomics technologies to study protein post-translational modifications and their roles in cellular processes, with applications in viral infections and disease mechanisms. Education: BSc in Chemistry, UMIST (now The University of Manchester), 1999 PhD in Biological Mass Spectrometry, University of Manchester, 2003 Postdoctoral Research, University of Southern Denmark (with Ole Jensen), 2005-2008 Postdoctoral Research, Utrecht University (with Albert Heck), 2008 Professor Mohammed's research centers on developing novel mass spectrometry approaches for large-scale characterization of protein post-translational modifications (PTMs). His group innovates in chromatographic techniques for single-cell proteomics, creates materials for PTM enrichment (glycosylation/phosphorylation), and applies these tools to study viral infections (SARS-CoV-2), cell cycle regulation, and signaling pathways. His work bridges chemistry, biochemistry, and cell biology to understand dynamic protein functions in health and disease. His recent publications (2023-2025) demonstrate strong emphasis on viral proteomics, particularly virus-host RNA-binding protein interactions, and innovations in mass spectrometry fragmentation techniques and chromatography. Key themes include viral remodeling of host cells, new labeling strategies for PTMs, and advancements in single-cell proteomics, with significant implications for understanding viral pathogenesis. Scientific Awards: No specific awards or fellowships were detailed in the source material. Advising and Grants: Information regarding graduate students supervised or specific research grants was not provided in the available text. As an active research group leader, Professor Mohammed likely mentors PhD students and secures competitive funding for proteomics research. Laboratories and Collaborations: Professor Mohammed leads a research group at Oxford focused on proteomics technology development. He collaborates extensively with the Ben Davis group on PTM detection materials and across the university on biochemical applications. At the Rosalind Franklin Institute, he heads the Mechanistic Proteomics programme to unravel protein functions through advanced proteomic methods.

David N. Langelaanمشاهده پروفایل

دانشیار

• Structural Biology
• Protein-Protein Interactions
• Cellular Signaling
• +۵ مورد دیگر

David N. Langelaan is an Associate Professor in the Department of Biochemistry and Molecular Biology at Dalhousie University, within the Faculty of Medicine. He holds a PhD from Dalhousie University and has been a department member since 2016. His research focuses on structural biology, protein-protein interactions, cellular signaling, and protein engineering. Key projects include hydrophobin characterization and engineering, studying MITF's role in melanoma and development, and analyzing rhodoquinone biosynthesis in anaerobic environments. Education: PhD, Dalhousie University. Research Themes: Structural biology, protein assemblies, microbial biochemistry, cancer biology. His lab employs techniques like NMR spectroscopy, X-ray crystallography, and isothermal titration calorimetry. Current lab members include graduate students (Raymond He, Trilok Neupane) and honours students (Alex Bouchard, Janani Venkat). Funding is provided by agencies such as NSERC, CFI, and the Dalhousie Medical Research Foundation. Publications highlight contributions to antimicrobial mechanisms, transcription factor signaling, and hydrophobin self-assembly. Recent work examines MITF coactivator interactions and rhodoquinone biosynthesis pathways in bacteria.

Michael Boutrosمشاهده پروفایل

استاد

• Functional Genomics
• Structural Genomics
• Wnt Signaling
• +۷ مورد دیگر

Michael Boutros is a Full Professor at Heidelberg University and Head of Division at the German Cancer Research Center (DKFZ). He currently serves as Dean of the Medical Faculty at Heidelberg University (since 2023) and Director of the Marsilius Kolleg (since 2020). He has held leadership roles including Coordinator of the Functional and Structural Genomics Program at DKFZ (2014–2023) and Acting Scientific Director (2015–2016). His academic base is within the Medical Faculty, focusing on molecular oncology and functional genomics. PhD, Witten/Herdecke University (1993–1996) Postdoctoral Research, Harvard Medical School (1999–2003) MPA, John F. Kennedy School of Government, Harvard University (1999–2001) Additional training: Cold Spring Harbor Laboratory, SUNY Stony Brook His research centers on Wnt signaling, functional genomics, and cancer pathways. He leads major research initiatives such as CRC 1324 on Wnt signaling and the ERC Synergy Grant DECODE. His work integrates high-throughput screening, CRISPR, and systems biology to dissect signaling networks in cancer and development. He has pioneered genome-wide RNAi and CRISPR screens to identify novel regulators of Wnt signaling across models. The 15 most recent articles reflect a strong focus on Wnt pathway regulation using functional genomics in both Drosophila and mammalian systems. Themes include high-throughput screening, CRISPR-based validation, cross-species conservation, and therapeutic targeting. Keywords span Cancer Biology, Systems Biology, and Signal Transduction, with subfields like RNAi, ubiquitination, stem cell regulation, and machine learning in image analysis. Michael Boutros has received numerous scientific honors: Elected member, Leopoldina National Academy of Sciences (2022) Elected member, Heidelberg Academy of Sciences (2022) EMBO Member (2013) ERC Advanced Grant (2012) Johann-Georg Zimmermann Research Award (2007) EMBO Young Investigator (2005) Member, 'Die Junge Akademie' (2003) He has been a recipient of the Emmy-Noether Program, McCloy Fellowship, Boehringer Ingelheim PhD Fellowship, Studienstiftung Fellowship, and Fulbright Fellowship. As a mentor and research leader, he has supervised numerous early-career scientists and coordinated large collaborative grants including the FP7 'CancerPathways' project. He currently serves as Speaker of the Research and Strategy Commission at Heidelberg University and Managing Director of the Health and Life Science Alliance Heidelberg Mannheim. He leads the CRC 1324 on Wnt signaling and is Coordinating PI of the ERC Synergy Grant DECODE. He is also Spokesperson of DFG Research Group 1036 and Coordinator of the former FP7 Coordinated Project 'CancerPathways'. His lab employs cutting-edge functional genomics tools to decode signaling networks in cancer and development.

David B. Bensimonمشاهده پروفایل

استاد

• Biophysics
• Single-Molecule Studies
• DNA Mechanics
• +۷ مورد دیگر

David B. Bensimon is a world-leading biophysicist and Professor in the Department of Chemistry and Biochemistry at the University of California, Los Angeles, holding the prestigious Regent's Professor title since 2007. He maintains a dual academic position, serving as Directeur de Recherche at the French National Center for Scientific Research (CNRS) at the Ecole Normale Supérieure (ENS) in Paris while teaching and conducting research at UCLA for one quarter each year. His academic journey began with a Ph.D. from the University of Chicago in 1986 under Leo Kadanoff, followed by postdoctoral research at Bell Laboratories and ENS Paris. Professor Bensimon's research spans multiple frontiers in biophysics and molecular biology, with particular expertise in single-molecule studies of nucleic acids and their proteins. His laboratory pioneered the Magnetic Trap technique for manipulating individual DNA molecules, enabling groundbreaking investigations into DNA mechanics, topoisomerase interactions, and molecular combing. His recent work has expanded into optogenetics, developmental biology using zebrafish models, and cancer research, with significant contributions to understanding how single-cell oncogene activation leads to tumorigenesis. His research output shows remarkable breadth across disciplines, with recent publications spanning biophysics, developmental biology, cancer research, and genomic technology development. Bensimon's work on opto-chemical tools has particularly transformed how researchers can control biological processes with unprecedented spatiotemporal precision, especially in zebrafish models. His laboratory has developed photoactivatable versions of key molecular tools including Cas9 (OptoCas9) and cyclofen systems that allow precise control of protein activity at the single-cell level. 2007 Regent's Professor at UCLA 1997 Vinci of Excellence Award for phospholipid vesicle research 1994 Jacques Monod Prize for Molecular Combing discovery Special Prize of the French Physical Society for DNA mechanics work ICAM Fellow KITP-UCSB Representative Bensimon has made significant contributions to both basic science and translational applications, co-founding Depixus for nucleic acid sequencing and epigenetic analysis. His laboratory continues to push boundaries in single-molecule biophysics while expanding into developmental biology and cancer research, with recent work demonstrating that activation of kRas in dedifferentiated cells increases tumorigenesis probability by two orders of magnitude. His mentorship has produced notable researchers including X. Michalet, and his theoretical work extends to the philosophical unification of scientific disciplines as evidenced by his book "The Unity of Science".

Andrés J. Garcíaمشاهده پروفایل

استاد

• Bioengineering
• Regenerative Medicine
• Biomaterials
• +۷ مورد دیگر

Andrés J. García is the Executive Director of the Parker H. Petit Institute for Bioengineering & Bioscience and a Regents’ Professor in the George Woodruff School of Mechanical Engineering at Georgia Institute of Technology. His research focuses on engineered biomaterials for regenerative medicine, including tissue repair, inflammation modulation, and cell adhesion mechanisms. He co-founded three startups (CellectCell, CorAmi Therapeutics, iTolerance) and holds multiple patents in biomaterials and drug delivery systems. Education: Ph.D., University of Pennsylvania, 1996 M.S.E., University of Pennsylvania, 1992 B.S., Cornell University, 1991 Research Interests: García’s work integrates engineering, materials science, and cell biology to develop biomaterials that direct cellular responses. Key areas include: Biomaterial platforms for bone repair and vascularization Immunomodulatory hydrogels for islet transplantation Antibacterial hydrogels for implant infection control Organoid generation using synthetic hydrogels Mechanisms of cell adhesion and mechanotransduction Publications: Over 30+ peer-reviewed articles in Nature Communications , Science Advances , Biomaterials , and others, highlighting innovations in hydrogel design, stem cell therapies, and biomaterial-driven tissue repair. Awards: Member of both the National Academy of Engineering and National Academy of Medicine (2021), Clemson Award for Basic Research (2012), and Fellowships with the American Society of Mechanical Engineers and AAAS. Labs/Teams: Leads the García Laboratory, collaborating across disciplines to translate biomaterials research into clinical applications. Active in startup partnerships and federal grants (e.g., NSF, NIH).

Ben Allenمشاهده پروفایل

دانشیار

• Hedgehog Signaling
• Developmental Biology
• Signal Transduction Pathways
• +۳ مورد دیگر

Ben Allen is an Associate Professor in the Department of Cell and Developmental Biology at the University of Michigan. His research focuses on the mechanisms of growth factor and morphogen signaling, particularly Hedgehog (HH) signaling in development, tissue homeostasis, and cancer. Employing techniques such as mouse genetics, chicken in ovo electroporations, and biochemical analyses, his lab investigates HH signaling regulation in embryonic/postnatal development and diseases like pancreatic cancer. Recent work explores HH pathway roles in taste organ repair, kidney morphogenesis, and immunosuppressive tumor microenvironments. The lab's publications highlight interdisciplinary approaches, with keywords spanning developmental biology, cancer biology, and signal transduction. Subfields include pancreatic cancer progression, ciliary transport, GLI transcription factor dynamics, and tissue-specific signaling modulation. Collaborations with cancer researchers and regenerative medicine specialists are evident. Allen's group also contributes to science education initiatives, exemplified by their "Developing Future Biologists" program targeting underrepresented undergraduate students.